Role of Intestinal Autophagy in the Pathogenesis of Alcohol Associated Liver Disease
肠道自噬在酒精相关性肝病发病机制中的作用
基本信息
- 批准号:10566088
- 负责人:
- 金额:$ 50.03万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2023
- 资助国家:美国
- 起止时间:2023-07-01 至 2023-09-30
- 项目状态:已结题
- 来源:
- 关键词:AffectAlcohol consumptionAlcoholic Liver DiseasesAlcoholsAspirinAttenuatedAutophagocytosisAutophagosomeBiogenesisCatabolic ProcessCell physiologyCellsChronicColonCytoplasmDataDisease ProgressionEndotoxemiaEnzymesEpithelial CellsEpitheliumEthanolExhibitsExtravasationFDA approvedFunctional disorderGTF2H1 geneHealthHeavy DrinkingHomeostasisImpairmentIntestinal MucosaIntestinal permeabilityIntestinesInvestigationLarge IntestineLeaky GutLiver diseasesLysosomesMethodsMissionMolecularMorbidity - disease rateMuramidaseMusNational Institute on Alcohol Abuse and AlcoholismNuclearOrganOrganellesOrganoidsPaneth CellsPathogenesisProcessPublic HealthResearchResearch SupportRisk FactorsRoleSmall IntestinesSmall intestine mucous membraneTestingalcohol effectalcohol exposurealcohol misusebactericidedysbiosisfeedinggastrointestinal epitheliumgut homeostasisgut microbiotainsightintestinal barrierintestinal cryptintestinal epitheliumliver functionliver injurymacromoleculemicrobial compositionmicrobiotamortalitynovelpreservationsenescencetherapeutic targettranscription factortreatment strategy
项目摘要
Abstract:
Alcohol-Associated Liver Disease (ALD) continues to be a major cause of morbidity and mortality worldwide.
Currently, there are no FDA-approved therapies that block or reverse ALD progression. Understanding the key
steps that promote ALD progression is essential to identifying new treatment targets and methods that alleviate
ALD. Prominent among the factors that contribute to ALD progression is the alcohol-induced disruption of
intestinal barrier integrity, accompanied by microbial flora imbalance (dysbiosis). Both these promote gut and
liver injury. However, the cellular/molecular mechanisms by which excessive drinking triggers dysbiosis and
compromises intestinal barrier integrity must be clearly established. Here, we present unique, exciting new data,
showing that chronic ethanol (EtOH) feeding disrupts intestinal autophagy, a crucial intracellular catabolic
process that begins with the formation of autophagosomes (AV), which sequester and deliver senescent
macromolecules and organelles to lysosomes for breakdown in this organelle. The degraded species are
replenished by synthesis. This process of rapid and constant turnover preserves the specialized functions of all
cells, but especially intestinal cells and it regulates intestinal microbial composition as well, thereby, maintaining
gut homeostasis. Our understanding of autophagy’s role in preserving intestinal barrier function has progressed
significantly, but we need a better understanding of how EtOH misuse disrupts gut autophagy to impair barrier
function. Our objective is to ascertain the mechanism(s) by which EtOH exposure dysregulates autophagy in
intestinal cells to compromise gut barrier integrity and promotes alcohol-induced liver injury. We propose the
following Specific Aims: Aim 1. Investigate how EtOH-induced lysosome disruption affects epithelial cell barrier
integrity; Aim 2) Clarify the effects of EtOH-induced autophagy disruption on Paneth cell function and Aim 3)
Ascertain how EtOH-induced liver injury is exacerbated by deficient intestinal autophagy but is alleviated by
autophagy reactivation in the gut.
抽象的:
酒精相关性肝病 (ALD) 仍然是全世界发病和死亡的主要原因。
目前,尚无 FDA 批准的疗法可以阻止或逆转 ALD 进展。
促进 ALD 进展的步骤对于确定新的治疗目标和方法至关重要
导致 ALD 进展的重要因素是酒精引起的 ALD 破坏。
肠道屏障完整性,伴随着微生物菌群失衡(生态失调)。
然而,过量饮酒引发菌群失调的细胞/分子机制。
必须明确确定损害肠道屏障完整性的因素,在这里,我们提出了独特的、令人兴奋的新数据,
研究表明,长期摄入乙醇(EtOH)会破坏肠道自噬,这是一种重要的细胞内分解代谢
这个过程始于自噬体 (AV) 的形成,它隔离并传递衰老细胞
大分子和细胞器进入溶酶体,在该细胞器中分解。
这种快速而持续的周转过程保留了所有的特殊功能。
细胞,特别是肠道细胞,它还调节肠道微生物组成,从而维持
我们对自噬在保护肠道屏障功能中的作用的理解已经取得进展。
显着,但我们需要更好地了解乙醇滥用如何破坏肠道自噬从而损害屏障
我们的目标是确定乙醇暴露导致自噬失调的机制。
肠道细胞会损害肠道屏障的完整性并促进酒精引起的肝损伤。
具体目标如下: 目标 1. 研究乙醇诱导的溶酶体破坏如何影响上皮细胞屏障
完整性;目标 2) 阐明乙醇诱导的自噬破坏对潘氏细胞功能的影响和目标 3)
确定肠道自噬缺陷如何加剧 EtOH 诱导的肝损伤,而通过以下方式减轻肝损伤:
肠道中的自噬重新激活。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Paul Gideon Thomes其他文献
Paul Gideon Thomes的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Paul Gideon Thomes', 18)}}的其他基金
Role of Lysosome Damage in ALD Pathogenesis
溶酶体损伤在 ALD 发病机制中的作用
- 批准号:
10668006 - 财政年份:2023
- 资助金额:
$ 50.03万 - 项目类别:
相似国自然基金
分子生物学联合CT血管成像研究不同种类酒及饮酒量对猪血管弹性的作用机制
- 批准号:81371548
- 批准年份:2013
- 资助金额:75.0 万元
- 项目类别:面上项目
相似海外基金
Roles of peroxisomal dysfunction in alcohol-related liver disease
过氧化物酶体功能障碍在酒精相关性肝病中的作用
- 批准号:
10659535 - 财政年份:2023
- 资助金额:
$ 50.03万 - 项目类别:
Examining Individuals' Exposure to Alcohol Environments Using Novel Responsive Buffers
使用新型响应缓冲器检查个人对酒精环境的暴露情况
- 批准号:
10752468 - 财政年份:2023
- 资助金额:
$ 50.03万 - 项目类别:
Social determinants of fatty liver disease and its racial/ethnic disparities: The Multi-Ethnic Study of Atherosclerosis
脂肪肝疾病的社会决定因素及其种族/民族差异:动脉粥样硬化的多民族研究
- 批准号:
10649813 - 财政年份:2023
- 资助金额:
$ 50.03万 - 项目类别:
Multifunctional Nanoparticle Platform to Prevent Alcohol-Associated HCC Development
多功能纳米颗粒平台可预防酒精相关的 HCC 发展
- 批准号:
10736984 - 财政年份:2023
- 资助金额:
$ 50.03万 - 项目类别:
Using patient-level decision modeling to improve use of treatments for alcohol use disorder
使用患者层面的决策模型来改善酒精使用障碍治疗的使用
- 批准号:
10712474 - 财政年份:2023
- 资助金额:
$ 50.03万 - 项目类别: